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Brucellosis is a zoonotic bacterial infection that may persist for long periods causing relapses in antibiotic-treated patients. The
ability of Brucella to develop chronic infections is linked to their capacity to invade and replicate within the mononuclear
phagocyte system, including the bone marrow (BM). Persistence of Brucella in the BM has been associated with hematological
complications such as neutropenia, thrombocytopenia, anemia, and pancytopenia in human patients. In the mouse model, we
observed that the number of Brucella abortus in the BM remained constant for up to 168 days of postinfection. This persistence
was associated with histopathological changes, accompanied by augmented numbers of BM myeloid GMP progenitors, PMNs,
and CD4+ lymphocytes during the acute phase (eight days) of the infection in the BM. Monocytes, PMNs, and GMP cells were
identiﬁed as the cells harboring Brucella in the BM. We propose that the BM is an essential niche for the bacterium to establish
long-lasting infections and that infected PMNs may serve as vehicles for dispersion of Brucella organisms, following the Trojan
horse hypothesis. Monocytes are solid candidates for Brucella reservoirs in the BM.
1. Introduction
Brucellosis is a zoonotic bacterial infection caused by mem-
bers of the genus Brucella [1]. In humans, the disease is
long-lasting, displaying a variety of clinical and pathological
manifestations that may persist for months or years [2–5].
If the infection is not properly treated, it may cause death.
The ability of Brucella organisms to develop chronic
infections is linked to their competence to invade the mono-
nuclear phagocyte system, where they replicate within the
endoplasmic reticulum [6]. In addition, the poor proinﬂam-
matory responses induced at the onset of the infection [7],
together with the capacity of Brucella organisms to extend
the life of infected cells, are factors that contribute to the
pathogenicity of this microorganism [7, 8].
The persistence of Brucella organisms in humans occurs
in the lymph nodes, spleen, liver, bone marrow (BM),
reproductive organs, and joints [9, 10]. The bacterium is
isolated from the BM in about half of the human patients
with brucellosis [4]. However, in all brucellosis cases, the
BM displays histopathological alterations, whether or not
the bacterium is isolated from this tissue. Common hemato-
logical signs are neutropenia, thrombocytopenia, and
anemia, and in severe cases, pancytopenia has also been
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reported [4, 5, 11]. In most patients, the BM cellular alter-
ations ameliorate or disappear after antibiotic treatment [4].
Moreover, brucellosis transmission by BM transplantation
from seemingly healthy donors has been reported [12]. These
data indicate that even in those cases in which the bacterium
is not isolated from the BM, it still may be present, hidden
within cells.
Following experimentation in mice, it has been proposed
the BM may be the most relevant tissue for Brucella persis-
tence [13]. In addition, Brucella canis has been shown to
persevere in the BM at chronic stages of mouse infection
[14]. Here, we describe the persistence of Brucella abortus
in cells of the mice BM and propose that this tissue is
essential for establishing long-lasting chronic infections.
2. Materials and Methods
2.1. Infection Protocols. B. abortus 2308W expressing red
ﬂuorescent protein from Discosoma coral (B. abortus-RFP),
provided by Jean-Jacques Letesson (University Notre-Dame
de la Paix, Namur, Belgium) was used in all experiments.
BALB/c mice were supplied by the Escuela de Medicina
Veterinaria, Universidad Nacional, Costa Rica, and Labora-
torio de Ensayos Biológicos, Universidad de Costa Rica.
C57BL/6 mice were purchased from Charles River Laborato-
ries (Les Oncins, France), housed under speciﬁc pathogen-
free conditions, and handled in accordance with French
and European guidelines.
Mice were infected by the intraperitoneal route (i.p.) with
106 bacterial colony forming units (CFU) of B. abortus-RFP.
At diﬀerent phases of the infection, the spleen, liver, lymph
nodes, and bone marrow (BM) were collected. Then, the
organs subjected to bacterial counts, histopathological exam-
ination, and cells analyzed by ﬂow cytometry, as described
elsewhere [15, 16]. Experimentation in mice was conducted
following the guidelines and consent of the “Comité Institu-
cional para el Cuido y Uso de los Animales de la Universidad
de Costa Rica” (CICUA-47-12) and in accordance with the
corresponding Animal Welfare Law of Costa Rica (Law
9458). All animals were kept in cages with food and water
ad libitum under biosafety containment conditions.
BM cells were also isolated and infected ex vivo in the
presence of anti-Brucella antibodies, following previous pro-
tocols [16]. Brieﬂy, BM cells were isolated from the tibia and
femur of B. abortus-RFP-infected mice at 8 and 30 days of
postinfection by ﬂushing bones with HBSS (no calcium, no
magnesium) or RPMImedium. BM cells were then incubated
with B. abortus-RFP at MOI of 50 bacteria/cell at 37°C for 2
hours, washed with PBS, suspended in HBSS, and subjected
to examination. The number of CFUs infecting enriched
BM-derived PMNs was estimated by lysing the cells and
counting bacteria in agar plates [17].
2.2. Immunoﬂuorescence. BM cells (50 to 100μl resuspended
in DMEM at a concentration of 106 cells/ml) were loaded on
alcian blue-coated coverslips (Sigma) and incubated for
20min at 37°C to allow cell attachment. Twenty minutes
Antigenﬁx (Diapath) was used for ﬁxation. Once ﬁxed onto
coverslips, cells were washed with PBS and slides were
mounted using ProLong Gold Antifade reagent containing
DAPI (Thermo Fisher Scientiﬁc). Slides were observed
with confocal microscope (Leica TCS SP8) as described
before [18]. Image analyses were performed using the
ZEN 2011 software.
2.3. Histopathology. For histopathological studies, the spleen,
lymph nodes, and BM from infected and PBS-treated mice
were ﬁxed in 10% neutral buﬀered formalin, processed and
stained with hematoxylin and eosin or Giemsa stain [19].
The histopathological score (from 0 (negative) to 4 (severe))
was determined by semiquantitative analysis as previously
described [20–22].
2.4. Flow Cytometry. For ﬂow cytometric analyses, cell surface
markers were stained using the following antibodies: BV421
anti-CD11b (M170), BV711 anti-Ly6G (1A8), BV785 anti-
F4/80 (BM8), and BV570 anti-CD4 (RM4–5) antibodies were
purchased from BioLegend; AF647 anti-CD34 (RAM34),
BV711 anti-CD8α (53-6.7), and BV650 anti-CD3 (245-
2CII) from BD Biosciences; and Alexa Fluor 488 and APC
both anti-CD115 (AFS98), PE anti- Ly6G (1A8), Ef450 anti-
CD45R/B220 (RA3-6B2), PE Cy7 anti-CD19 (1D3), and
AF700 anti-CD44 (1M7) antibodies from eBiosciences; and
APC Cy7 anti-CD16/32 (2.4G2), BV510 anti-Sca-1 (D7),
and BV605 CD117/c-kit (2B8) from BDBiosciences. An anti-
body staining scheme is provided in Table S1. Cells were
identiﬁed according to the staining scheme and the percent-
age of each cell type determined in relation to all living cells
of bone marrow at 8 and 30 days of postinfection. Cell viabil-
ity was evaluated using Fixable Viability Dye UV (eBios-
ciences). Cells were ﬁxed with Antigenﬁx for 20min before
the acquisition. Multiparameter ﬂow cytometry was per-
formed using a FACS LSRII UV (BD Biosciences) or Guava
easyCyte (Millipore). Flow cytometry data were analyzed
using the FlowJo software, version 10.0.7 (Tree Star Inc.).
2.5. Statistics. One-way analysis of variance (ANOVA)
followed by Dunnett’s test or multivariate analysis of
variance (MANOVA) was used to determine statistical
signiﬁcance in the diﬀerent assays. The JMP (https://www.
jmp.com) and GraphPad Prism software (https://www.
graphpad.com) were used for statistical analysis. Data were
processed in Microsoft Oﬃce Excel 2015.
3. Results
According to bacterial loads, histopathological alterations,
and immune response, murine brucellosis has been divided
into four stages: onset of infection, acute phase, chronic
phase, and chronic declining phase [23] (Figure 1(a)). After
infection, B. abortus CFU counting was performed from the
spleen, lymph nodes, and BM during the lapse of 168 days of
postinfection (Figure 1(a)). Bacterial loads and kinetic pro-
ﬁles of the spleen and lymph nodes were similar. A signiﬁ-
cant bacterial increase was observed in the lymph nodes
and spleen at the chronic steady phase III (28 days of post-
infection), followed by a decrease in the bacterial numbers
at the chronic declining phase IV and until the end of the
experimentation. In the BM, B. abortus infection steadily
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persisted throughout all four phases, until day 168, when the
CFU/g loads were signiﬁcantly higher than those of lymph
nodes and spleen. Similar results were obtained with
C57BL/6 mice (not shown). The weight of the spleens
increased until day 28 and then decreased until the end of
the experiment, following a pattern similar to that of the
kinetics of the CFU count (Figure 1(b)). Even though the
number of CFU/g of BM was relatively high, the absolute
numbers of B. abortus BM-infected cells were low at 8 (acute
phase) and 30 (chronic phase) days of postinfection, suggest-
ing that few infected cells harbored many bacteria
(Figure 1(c)). However, a high number of bacteria was
observed in some cells, a phenomenon that may account
for the discrepancy between the CFU/g and the number of
infected cells.
It has been demonstrated that most Brucella-infected
human patients display histopathological alterations,
whether or not the bacterium is isolated from the BM [4].
As shown in Figure 2(a), granulomatous inﬂammation was
more severe and diﬀuse at acute stages than the multifocal
chronic phase in the BM, spleen, and liver. At the acute
phase, the inﬂammatory process was characterized by coa-
lescing to diﬀuse inﬂammation with larger and cell-rich
granulomas, while in the chronic phase, granulomatous
inﬂammation was multifocal with smaller and fewer cellu-
lar lymphohistiocytic aggregates. Epithelioid macrophages
predominate during the inﬂammatory process at early
stages, reducing in number with chronicity. Classical gran-
uloma formation was observed more clearly in the spleen
and liver, while bone marrow developed an epithelioid
macrophage-rich aggregate with scattered lymphocytes,
which reduced its size and cellularity over time. Compared
to the spleen, bone marrow granulomatous inﬂammation
was more severe in the ﬁrst two weeks of infection. After
four weeks of infection, the spleen and bone marrow
presented similar inﬂammation scores, though the granu-
lomatous inﬂammation decreased in both tissues afterward
(Figure 2(b)).
The cellular changes in the BM of infected mice were
estimated by ﬂow cytometry. At 8 days of postinfection, we
observed changes in the hematopoietic cell population. At
day 8 of postinfection, the percentage megakaryocyte-
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Figure 1: B. abortus persists in bone marrow during the course of infection. Mice were infected with B. abortus-RFP. (a) Spleen, lymph nodes,
and BM were collected, and CFUs determined at diﬀerent phases of infection [23]: the onset of infection (I), the acute phase (II), the chronic
steady phase (III), and the chronic declining phase (IV). Each bar is the mean (±1 SD) of an experiment. Values of ∗∗p < 0 01 are indicated in
relation to spleen and lymph node bacterial loads. (b) Before CFU determination, the spleens were weighted at each time of examination. (c)
BM cells were isolated from the tibia and femur of B. abortus-RFP- (red intracellular bacteria) infected mice at 8 and 30 days of postinfection
mounted using ProLong Gold containing DAPI (blue nuclei). Microscope images are captured at 60x magniﬁcation confocal microscope.
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erythrocyte progenitor (MEP) decreased compared to the
BM of noninfected mice (data not shown). Contrarily, the
percentage of granulocyte-monocyte progenitors (GMP)
signiﬁcantly increased. Likewise, neutrophils (PMN) and
CD4+ lymphocyte populations signiﬁcantly increased at 8
days of postinfection (Figure 3(a)). The increase of CD8+
cells was evident, but not signiﬁcant (p < 0 05).
In order to estimate the proﬁciency of BM cells to inter-
nalize B. abortus, we performed an ex vivo infection. For this,
BM cells were infected with B. abortus-RFP in the presence of
anti-Brucella antibodies. As shown in Figure 3(b), close to
32% of the BM cells were infected; of these, over 90% were
identiﬁed as PMNs [16].
Flow cytometry analysis of BM from infected mice ren-
dered three main cell types containing B. abortus: monocytes,
PMNs, and GMPs (Figure 3(c)). At 8 days of postinfection,
the proportion of PMN-containing bacteria was greater than
other cells. Strikingly, the number of infected PMNs dramat-
ically decreased after 30 days. The proportion of infected
monocytes remained similar at 8 and 30 days of postinfec-
tion. Although at early stages of infection close to 3% of the
GMP-contained bacteria, the number of infected cells practi-
cally disappeared at later times (Figure 3(c)).
4. Discussion
At initial stages of infection, Brucella invades target organs,
before a strong activation of the innate immune system
and stimulation of antimicrobial mechanisms [7, 24]. This
immunological gap allows the bacterium to colonize, repli-
cate, and hide within cells of the mononuclear phagocyte
system. Linked to this is the observation that B. abortus
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Figure 2: Brucella abortus induces a granulomatous inﬂammation in bone marrow. (a) Mice were infected with B. abortus-RFP. The spleen,
liver, and BMwere collected at diﬀerent phases of infection and subjected to histopathological examination. (b) Granulomatous inﬂammation
was scored from 0 (negative) to 4 (severe) [19] in BM over time. Each bar is the mean (±1 SD) of an experiment. Value of ∗p < 0 05 is indicated
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infection remains sequestered within BM cells for a pro-
tracted period, without signiﬁcant changes in the bacterial
loads. These phenomena propose a mechanism for Brucella
persistence.
Granuloma formation, commonly observed in long-
lasting infections, is an attempt to eliminate the microorgan-
isms [25, 26]. In tuberculosis, it has been proposed that
granulomas provide a bacterial safety shelter from the host
immune response [27]. The higher number of granulomas
in the BM and the permanence of these structures indicate
the struggle of immune cells for eliminating B. abortus. This
is also depicted by the signiﬁcantly higher number of CD4+
lymphocytes in the BM at early stages of infection, which in
brucellosis correlates with Th1 polarization [28].
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Figure 3: Bone marrow leukocyte variation at diﬀerent stages of infection. (a) BM cells from B. abortus-infected mice were collected and
subjected to multiparameter ﬂow cytometry analysis. Cells were identiﬁed according to the staining scheme (Table S1) and the percentage
of each cell type determined in relation to all living cells of bone marrow at 8 and 30 days of postinfection. Values of ∗p < 0 05 or ∗∗p <
0 01 are indicated in relation to control noninfected mice at 8 and 30 days of postinfection. (b) Whole BM cells were collected and
infected ex vivo with B. abortus-RFP. Infected cells were gated based on the RFP (red) positivity, and the total percentages of infected cells
were quantiﬁed. (c) BM cells from B. abortus-RFP-infected mice were collected and subjected to multiparameter ﬂow cytometry analysis.
Infected cells were gated based on the RFP (red) positivity, identiﬁed and quantiﬁed according to the staining scheme (Table S1) at 8 a 30
days of postinfection. Each bar is the mean (±1 SD) of an experiment. Values of ∗∗p < 0 01 are indicated.
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The most abundant infected BM cells at the acute
phase of murine infection (once antibodies against
Brucella have developed) were PMNs. This result is remi-
niscent of the ex vivo infection of BM cells. Indeed, we
have demonstrated that a large proportion of ex vivo B.
abortus-infected BM cells are PMNs and that these leuko-
cytes are unable to kill the ingested bacteria [16]. Despite
this, it is unlikely that PMNs are the main reservoirs for
Brucella in the BM. Indeed, B. abortus does not replicate
in these cells and these infected leukocytes died prema-
turely [16]. Rather, PMNs may serve as vehicles for dis-
persing the bacterium, functioning as Trojan horses, as
previously proposed [16, 18].
A small proportion of GMP cells in the BM were also
infected at the acute phase of infection. This is unexpected
since uncommitted progenitors such us GMP cells are not
yet considered phagocytic cells [29]. However, at later time
points, the proportion of infected cells was negligible.
Moreover, the total number of GMP cells increased at
early times of infection, diminishing afterward. These
cellular variations correlate with the pathological changes
of the BM. A similar phenomenon has been observed in
human brucellosis cases [4, 30].
To our knowledge, this is the ﬁrst time that myeloid
oligopotent progenitor stem cells, lacking a developed phago-
cytic machinery, have been shown to become infected with
Brucella organisms. Even though it is common to observe
extramedullary hematopoiesis in the spleen of Brucella-
infected mice [23], here we demonstrate for the ﬁrst time
Brucella-infected hematopoietic oligopotent stem cells resid-
ing in the BM. During emergency myelopoiesis, self-
renewing GMPs in patches (pGMPs) build GMP clusters
and diﬀerentiate into clustering GMPs (cGMPs). These
GMP clusters can diﬀerentiate into mature cells until com-
plete disappearance of the GMP clusters [31, 32]. Moreover,
it has been shown that the increasing number of myeloid pro-
genitors can promote microbial persistence in the organism
[33]. All these ﬁndings make us speculate that B. abortus
infects myeloid oligopotent progenitor stem cells and may
interfere to induce GMP diﬀerentiation into infected-
diﬀerentiated cells. Whether the reduced number of infected
nonphagocytic erythrocytes and B cells [34, 35] originates
from BM-infected progenitor cells remains unknown.
Despite the histopathological changes of the B. abortus-
infected BM, and the low numbers of infected monocytes,
the proportion of these leukocytes remained constant and
persistent. It is well known that during granuloma forma-
tion, monocytes diﬀerentiate into macrophages, epithelioid
cells, and dendritic Langerhans-type giant cells [36]. More-
over, Brucella is able to survive in monocytes and inhibits
their programmed cell death [8]. Join-Lambert et al. [37]
showed that Listeria monocytogene-infected myeloid cells
in the bone marrow play a crucial role in the pathophysi-
ology of meningoencephalitis by releasing infected cells
into the circulation. Therefore, BM monocytes are ﬁrm
candidates for Brucella reservoirs in the BM. These cells
may be the source of the frequent relapses observed in
antibiotic-treated individuals, even several years after the
primo infection [38, 39].
5. Conclusions
Bacterial persistence, chronicity, and relapses are major
problems in brucellosis. Within this context, we concluded
(i) that loads of B. abortus in the BM remain constant and
are long lasting; (ii) that B. abortus-infected BM displays
histopathological modiﬁcations associated with augmented
numbers of multipotent progenitor and active hematopoietic
stem cells, PMNs, and CD4+ lymphocytes during the acute
phase of the infection; and (iii) that the three types of
infected cells in the BM are monocytes, PMNs, and GMP
cells. In addition, we hypothesize that (iv) BM PMNs may
serve as vehicles for dispersion of Brucella, following the
Trojan horse hypothesis; (v) that B. abortus-infected mye-
loid oligopotent progenitor cells may diﬀerentiate into
mature infected cells; and (vi) that monocytes are the most
likely Brucella reservoirs in the BM and that these cells
may be the source of the frequent relapses observed in
antibiotic-treated individuals.
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